Approved Drugs
Showing 133–144 of 204 results
-
Approved Drugs
Nimodipine | L-type calcium channel blocker
Nimodipine (66085-59-4) is an L-type calcium channel blocker.1 Prevents age-induced learning deficits in a rat model.2 Facilitates recovery of func...$50.00 – $180.00 Select options -
Approved Drugs
Nitrendipine | L-type Ca channel blocker
Nitrendipine (39562-70-4) is a clinically useful L-type calcium blocker. References/Citations: 1) Meyer et al., (1981), (Synthesis and compar...$80.00 – $300.00 Select options -
Approved Drugs
Olaparib | PARP1 inhibitor
Olaparib (763113-22-0) is a highly potent and selective PARP-inhibitor with IC50 values of 5 nM and 1 nM for PARP-1 and PARP-2, respectively.1 In ...$40.00 – $116.00 Select options -
Approved Drugs
Oxaprozin | NFkB inhibitor
Oxaprozin (21256-18-8) is a clinically useful non-steroidal anti-inflammatory drug.1 In addition to typical NSAID COX inhibition, oxaprozin may als...$40.00 – $90.00 Select options -
Approved Drugs
Ozagrel HCl | Thromboxane synthase inhibitor
Ozagrel HCl (78712-43-3) is a potent and selective inhibitor of thromboxane (TXA2) synthetase (IC50 = 4 nM).1 Does not inhibit prostacyclin (PGI2) ...$48.00 – $210.00 Select options -
Approved Drugs
Panobinostat | HDAC inhibitor
Panobinostat (404950-80-7) is a potent inhibitor of class I and II HDACs.1 Cotreatment with panobinostat and an HSP90 inhibitor caused synergistic ...$60.00 – $240.00 Select options